Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Not Confirmed
Not Confirmed
05-09 December, 2025
Not Confirmed
Not Confirmed
06-10 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Industry Trade Show
Not Confirmed
05-09 December, 2025
Industry Trade Show
Not Confirmed
06-10 December, 2025
Digital content

27 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/arthex-biotech-to-participate-in-the-24th-annual-needham-virtual-healthcare-conference-302412852.html

11 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/arthex-biotech-announces-oral-presentation-on-atx-01-at-tides-europe-annual-meeting-2024-302300806.html

07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/arthex-biotech-announces-fda-rare-pediatric-designation-rpd-of-atx-01-for-the-treatment-of-myotonic-dystrophy-type-1-dm1-302298244.html

18 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/arthex-biotech-announces-first-patient-dosed-in-phase-i-iia-arthemir-trial-for-myotonic-dystrophy-type-1-dm1-302279972.html

28 Feb 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/arthex-biotech-receives-ind-clearance-from-fda-to-initiate-the-phase-i-iia-arthemir-trial-of-atx-01-for-myotonic-dystrophy-type-1-dm1-302073670.html

24 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/arthex-biotech-announces-presentations-at-the-19th-annual-meeting-of-the-oligonucleotide-therapeutics-society-ots-and-tides-europe-2023-301966056.html
ABOUT THIS PAGE